Business Overview
Achievements & highlights:
• Company specializes in the sale of medical & surgical products through the franchise model.
• We have expanded and stepped into Tamil Nadu (new territory) this year.
• We have opened 63 franchise outlets across Andhra Pradesh, Telangana & Tamil Nadu.
• Awarded Brand of The Year by Business Outreach.
• Awarded Franchise Business of the Year by Franchise India in Association with ISFA & TV9.
• Recognised and awarded as Top 100 Franchise Brands of India by Franchise India in association with The Franchising World.
• Featured in Amongst World’s top Magazine Entrepreneur in May 2022 with an article Starting Small to Make It Big.
• Featured in Amongst India’s Best Business Magazine Business Outreach this year with an article on India’s Most Trusted chain of pharmacy Revolutionizing healthcare with 3D Business.
• Projected revenue growth of 70% (CAGR) by expanding the franchise model to other states.
• Revenue is generated from the supply of medical goods, royalties, franchise fees, license fees and infrastructure fees.
• Revenue has increased as we entered new territory and opened more franchise outlets.
• Have tie up with manufacturers and distributors for product supply.
Products & Services Overview
• Retail pharmacy chain franchise supplying medical & surgical products.
• Diagnosing kiosk/stall.
• Supply of medicines, surgical & optical.
Capitalization Overview
• The business is funded by its shareholders and can be described as self-funded.
• Debts - Loan of Rs. 60 lahks from banks.
• Number of shareholders - 02.
• Number of directors - 04.
• Share percentage is 50% each between 2 shareholders.
Assets Overview
• Office infrastructure.
• Warehouse and stock point infrastructure.
• Desktops.
• Air conditioners.
• LED TVs.
• Warehouse software.
• All outlets integrated software.
Partial Stake Sale
USD
700 thousand
for
50.0%
stake
(Native Currency: INR 60,000,000)
Reason: For pan India expansion by establishing own outlets.
Includes physical assets worth
USD
117 thousand
In talks with 3 Investors